Ajooni Biotech Limited (NSE:AJOONI)
3.770
-0.060 (-1.57%)
Jun 19, 2026, 3:29 PM IST
Ajooni Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 4.19 | 68.3 | 4.28 | 3.09 | 0.57 |
Short-Term Investments | - | 4.4 | 0.02 | 3.26 | 1.18 |
Cash & Short-Term Investments | 4.19 | 72.7 | 4.3 | 6.35 | 1.75 |
Cash Growth | -94.24% | 1589.22% | -32.25% | 262.20% | -56.61% |
Accounts Receivable | 178.34 | 162.16 | 129.59 | 205.51 | 138.4 |
Other Receivables | 7 | 5.52 | 0.79 | 3.24 | 0.12 |
Receivables | 326.83 | 167.68 | 130.38 | 208.75 | 138.52 |
Inventory | 394.55 | 239.87 | 153.67 | 69.94 | 58.82 |
Prepaid Expenses | - | 1.37 | 3.14 | 1.41 | 0.27 |
Other Current Assets | 19.19 | 138.42 | 31.78 | 60.26 | 19.9 |
Total Current Assets | 744.77 | 620.04 | 323.28 | 346.71 | 219.27 |
Property, Plant & Equipment | 258.56 | 112.26 | 112.43 | 65.51 | 62.05 |
Long-Term Investments | 24.48 | 34.94 | 21.36 | 37.37 | 7.04 |
Other Intangible Assets | 3.6 | 4.79 | - | - | - |
Long-Term Deferred Tax Assets | 4.93 | 3.79 | 3.12 | 2.72 | 1.82 |
Other Long-Term Assets | 167.33 | 174.69 | 15 | 135 | - |
Total Assets | 1,204 | 950.51 | 475.2 | 587.31 | 290.18 |
Accounts Payable | 89.14 | 29.3 | 13.38 | 98.46 | 66.22 |
Accrued Expenses | 0.17 | 5.81 | 2.68 | 3.21 | 1.84 |
Short-Term Debt | - | - | - | 28.69 | 18.2 |
Current Portion of Long-Term Debt | 162.23 | - | 4.86 | 5.62 | 9.54 |
Current Income Taxes Payable | 15.3 | 10.24 | 8.75 | 5.42 | 4.48 |
Other Current Liabilities | 6.63 | 2.86 | 0.44 | 10.69 | 0.32 |
Total Current Liabilities | 273.47 | 48.21 | 30.11 | 152.09 | 100.59 |
Long-Term Debt | 15.4 | 19.4 | 16.82 | 17.47 | 25.76 |
Pension & Post-Retirement Benefits | 2.87 | 2.11 | 1.2 | 1.06 | - |
Other Long-Term Liabilities | - | - | 0 | 0.01 | -0 |
Total Liabilities | 291.74 | 69.72 | 48.13 | 170.62 | 126.35 |
Common Stock | 344.49 | 344.49 | 175.23 | 175.23 | 100.06 |
Additional Paid-In Capital | - | 431.86 | 177.97 | 177.97 | 30.07 |
Retained Earnings | - | 120.07 | 86.9 | 66.2 | 55 |
Comprehensive Income & Other | 567.43 | -15.63 | -13.02 | -2.7 | -21.31 |
Shareholders' Equity | 911.92 | 880.79 | 427.08 | 416.69 | 163.82 |
Total Liabilities & Equity | 1,204 | 950.51 | 475.2 | 587.31 | 290.18 |
Total Debt | 177.63 | 19.4 | 21.68 | 51.77 | 53.51 |
Net Cash (Debt) | -173.44 | 53.31 | -17.37 | -45.42 | -51.75 |
Net Cash Per Share | -1.00 | 0.31 | -0.20 | -0.76 | -1.02 |
Filing Date Shares Outstanding | 189.44 | 172.24 | 87.61 | 87.61 | 50.03 |
Total Common Shares Outstanding | 189.44 | 172.24 | 87.61 | 87.61 | 50.03 |
Working Capital | 471.29 | 571.83 | 293.18 | 194.63 | 118.68 |
Book Value Per Share | 4.81 | 5.11 | 4.87 | 4.76 | 3.27 |
Tangible Book Value | 908.32 | 876 | 427.08 | 416.69 | 163.82 |
Tangible Book Value Per Share | 4.79 | 5.09 | 4.87 | 4.76 | 3.27 |
Land | - | 59.15 | 59.15 | 20.21 | 11.17 |
Buildings | - | 28.94 | 18.32 | 18.51 | 18.51 |
Machinery | - | 77.68 | 71.23 | 60.92 | 59.02 |
Construction In Progress | - | 2.93 | 9.25 | 2.62 | - |